Literature DB >> 22922413

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.

A John Camm1, Gregory Y H Lip, Raffaele De Caterina, Irene Savelieva, Dan Atar, Stefan H Hohnloser, Gerhard Hindricks, Paulus Kirchhof.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22922413     DOI： 10.1093/eurheartj/ehs253

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  893 in total

Review 1.  Balancing ischaemia and bleeding risks with novel oral anticoagulants.

Authors:  Usman Baber; Ioannis Mastoris; Roxana Mehran
Journal:  Nat Rev Cardiol       Date:  2014-11-04       Impact factor: 32.419

Review 2.  Approach to the new oral anticoagulants in family practice: part 1: comparing the options.

Authors:  James Douketis; Alan David Bell; John Eikelboom; Aaron Liew
Journal:  Can Fam Physician       Date:  2014-11       Impact factor: 3.275

Review 3.  Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation.

Authors:  Eleni Korompoki; Filippos T Filippidis; Peter B Nielsen; Angela Del Giudice; Gregory Y H Lip; Joji B Kuramatsu; Hagen B Huttner; Jiming Fang; Sam Schulman; Joan Martí-Fàbregas; Celine S Gathier; Anand Viswanathan; Alessandro Biffi; Daniela Poli; Christian Weimar; Uwe Malzahn; Peter Heuschmann; Roland Veltkamp
Journal:  Neurology       Date:  2017-07-19       Impact factor: 9.910

4.  Dabigatran and vitamin K antagonists' use in naïve patients with non-valvular atrial fibrillation: a cross-sectional study of primary care-based electronic health records.

Authors:  Bogdan Vlacho; Maria Giner-Soriano; Edurne Zabaleta-Del-Olmo; Albert Roso-Llorach; Ana García-Sangenís; Rosa Morros-Pedrós
Journal:  Eur J Clin Pharmacol       Date:  2017-07-19       Impact factor: 2.953

5.  Cost-effectiveness of apixaban vs. other new oral anticoagulants for the prevention of stroke: an analysis on patients with non-valvular atrial fibrillation in the Greek healthcare setting.

Authors:  Kostas Athanasakis; Eleftheria Karampli; Dimitrios Tsounis; Aikaterini Bilitou; John Kyriopoulos
Journal:  Clin Drug Investig       Date:  2015-11       Impact factor: 2.859

Review 6.  Update on the Treatment of Spontaneous Intraparenchymal Hemorrhage: Medical and Interventional Management.

Authors:  Thomas J Cusack; J Ricardo Carhuapoma; Wendy C Ziai
Journal:  Curr Treat Options Neurol       Date:  2018-02-03       Impact factor: 3.598

7.  Combined aspirin and anticoagulant therapy in patients with atrial fibrillation.

Authors:  Charlotte H So; Mark H Eckman
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

8.  Robotic ablation of atrial fibrillation with a new remote catheter system.

Authors:  Alexander Wutzler; Thomas Wolber; Abdul Shokor Parwani; Martin Huemer; Philipp Attanasio; Florian Blaschke; Laurent Haegeli; Wilhelm Haverkamp; Firat Duru; Leif-Hendrik Boldt
Journal:  J Interv Card Electrophysiol       Date:  2014-04-29       Impact factor: 1.900

9.  Cardiac embolism after implantable cardiac defibrillator shock in non-anticoagulated atrial fibrillation: The role of left atrial appendage occlusion.

Authors:  Xavier Freixa; Rut Andrea; Victoria Martín-Yuste; Diego Fernández-Rodríguez; Salvatore Brugaletta; Mónica Masotti; Manel Sabaté
Journal:  World J Cardiol       Date:  2014-04-26

10.  Treatment of stand-alone atrial fibrillation with a right thoracoscopic approach employing a microwave or monopolar radiofrequency energy source: long-term results.

Authors:  Zbyněk Straka; Petr Budera; Pavel Osmančík; Marek Malý; Tomáš Vaněk
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.